Oracle Corporation (NYSE:ORCL – Get Free Report) shares traded down 4.7% during mid-day trading on Wednesday . The stock traded as low as $155.35 and last traded at $157.3840. Approximately 37,816,641 shares traded hands during trading, an increase of 38% from the average session volume of 27,378,137 shares. The stock had previously closed at $165.16.
Key Oracle News
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle is still being viewed as a major AI infrastructure beneficiary, with articles highlighting its large backlog, cloud demand, and long-term revenue potential as AI and OCI deployments expand. Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Positive Sentiment: Oracle Health announced an AI collaboration with Theator to improve surgical documentation, billing accuracy, and workflow automation, which could support Oracle’s healthcare software growth. Oracle Health Extends AI into the Operating Room in Collaboration with Theator
- Neutral Sentiment: Several analysts and market commentators argued the stock’s sell-off may be overdone, pointing to Oracle’s backlog and blue-chip status as reasons the weakness could be a mispricing rather than a fundamental break. Oracle Has the Biggest Backlog in the AI Industry. Here’s Why the Stock Is Still Down 49%.
- Negative Sentiment: The layoffs and related restructuring charges have intensified concerns that Oracle’s AI expansion is costly, with some investors worried about dilution, higher debt, and pressure on shareholder returns. Oracle Analyst Warns: Preferred Stock Conversions and ATM Issuances May Dilute Shareholders and Pressure Stock Price
Analyst Ratings Changes
ORCL has been the subject of several research reports. Wedbush decreased their price objective on shares of Oracle from $275.00 to $240.00 and set an “outperform” rating for the company in a report on Thursday, June 11th. Robert W. Baird dropped their target price on shares of Oracle from $300.00 to $200.00 and set an “outperform” rating on the stock in a report on Tuesday, March 10th. Barclays lifted their target price on shares of Oracle from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Thursday, June 11th. Wolfe Research reissued an “outperform” rating and set a $225.00 price target on shares of Oracle in a report on Thursday, June 11th. Finally, Sanford C. Bernstein raised their price target on Oracle from $319.00 to $325.00 and gave the stock an “outperform” rating in a research note on Thursday, June 11th. Two research analysts have rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $268.27.
Oracle Trading Down 4.7%
The company has a market capitalization of $452.64 billion, a P/E ratio of 27.00, a PEG ratio of 1.10 and a beta of 1.65. The company has a debt-to-equity ratio of 2.84, a quick ratio of 1.35 and a current ratio of 1.12. The stock has a fifty day moving average of $190.13 and a 200 day moving average of $176.74.
Oracle (NYSE:ORCL – Get Free Report) last released its quarterly earnings results on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.96 by $0.15. The business had revenue of $19.18 billion during the quarter, compared to analyst estimates of $19.10 billion. Oracle had a return on equity of 56.43% and a net margin of 25.37%.Oracle’s revenue for the quarter was up 20.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.70 earnings per share. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. As a group, equities research analysts anticipate that Oracle Corporation will post 6.45 EPS for the current fiscal year.
Oracle Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 24th. Investors of record on Friday, July 10th will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, July 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.3%. Oracle’s payout ratio is 34.31%.
Insider Transactions at Oracle
In other Oracle news, EVP Stuart Levey sold 15,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an average price of $176.19, for a total transaction of $2,642,850.00. Following the sale, the executive vice president owned 3,429 shares in the company, valued at approximately $604,155.51. This trade represents a 81.39% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 40.90% of the company’s stock.
Hedge Funds Weigh In On Oracle
A number of hedge funds have recently modified their holdings of the company. Xponance Inc. grew its holdings in Oracle by 1.8% during the 3rd quarter. Xponance Inc. now owns 406,544 shares of the enterprise software provider’s stock valued at $114,336,000 after buying an additional 7,320 shares in the last quarter. DDD Partners LLC purchased a new stake in shares of Oracle during the 4th quarter worth approximately $1,677,000. William Blair Investment Management LLC boosted its position in shares of Oracle by 28.6% during the 3rd quarter. William Blair Investment Management LLC now owns 1,107,586 shares of the enterprise software provider’s stock valued at $311,497,000 after acquiring an additional 246,243 shares during the last quarter. New Mexico Educational Retirement Board boosted its position in shares of Oracle by 4.2% during the 4th quarter. New Mexico Educational Retirement Board now owns 76,590 shares of the enterprise software provider’s stock valued at $14,928,000 after acquiring an additional 3,100 shares during the last quarter. Finally, KADENSA CAPITAL Ltd grew its holdings in shares of Oracle by 1,945.8% in the third quarter. KADENSA CAPITAL Ltd now owns 92,736 shares of the enterprise software provider’s stock valued at $26,081,000 after purchasing an additional 88,203 shares in the last quarter. 42.44% of the stock is currently owned by institutional investors.
About Oracle
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Read More
- Five stocks we like better than Oracle
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
